19589
L-2,4-Diaminobutyric acid monohydrochloride
≥98.0% (AT), ≥98.0% (TLC)
Synonym(s):
DAB
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C4H10N2O2 · HCl
CAS Number:
Molecular Weight:
154.60
PubChem Substance ID:
UNSPSC Code:
12352200
Beilstein/REAXYS Number:
6086583
MDL number:
assay
≥98.0% (AT), ≥98.0% (TLC)
form
powder or crystals
optical activity
[α]20/D +24±2°, c = 1.2% in 6 M HCl
technique(s)
ligand binding assay: suitable
color
white to off-white
application(s)
peptide synthesis
SMILES string
Cl[H].NCC[C@H](N)C(O)=O
InChI
1S/C4H10N2O2.ClH/c5-2-1-3(6)4(7)8;/h3H,1-2,5-6H2,(H,7,8);1H/t3-;/m0./s1
InChI key
BFPDKDOFOZVSLY-DFWYDOINSA-N
Biochem/physiol Actions
L-2,4-Diaminobutyric acid (DAB) is a substrate of diaminobutyrate-pyruvate transaminase (EC 2.6.1.46), an enzyme involved in an alternative polyamine biosynthesis pathway in bacteria.
L-2,4-Diaminobutyric acid (DAB, DABA), a non-metabolized amino acid, is useful as a selective GABA uptake inhibitor which may have antitumour activity against hepatoma cells.
Storage Class
11 - Combustible Solids
wgk
WGK 3
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ryo Inada et al.
World journal of gastroenterology, 21(7), 2159-2168 (2015-02-27)
To analyze the mismatch repair (MMR) status and the ARID1A expression as well as their clinicopathological significance in gastric adenocarcinomas. We examined the expressions of MMR proteins and ARID1A by immunohistochemistry in consecutive 489 primary gastric adenocarcinomas. The results were
Florence Coussy et al.
International journal of cancer, 145(7), 1902-1912 (2019-03-13)
Triple-negative breast cancer (TNBC) represents 10% of all breast cancers and is a very heterogeneous disease. Globally, women with TNBC have a poor prognosis, and the development of effective targeted therapies remains a real challenge. Patient-derived xenografts (PDX) are clinically
Mirko Manetti et al.
Journal of clinical medicine, 8(7) (2019-07-03)
Hemophilic arthropathy (HA) typically begins with proliferative synovitis that shares some similarities with inflammatory arthritides, in which the proinflammatory cytokine tumor necrosis factor (TNF)-α has a crucial pathogenetic role. Inappropriate release of TNF-α was shown to contribute to arthropathy development